Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125816261 | 12581626 | 1 | I | 20160712 | 20160712 | 20160722 | 20160722 | EXP | US-JUBILANT GENERICS LIMITED-1055387 | JUBILANT | JOURNAL: J COMMUNITY SUPPORTIVE ONCOL?AUTHOR: HOFFMANN MS, OVERMAN MJ, NATES JL?TITLE: ACUTE BENZODIAZEPINE TOXICITY EXACERBATED BY CONCOMINANT ORAL OLANZAPINE?VOLUME: 14(4) YEAR: 2016 PAGES: 178-179 | 61.00 | YR | F | Y | 0.00000 | 20160722 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125816261 | 12581626 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | 200221 | ||||||||||||
| 125816261 | 12581626 | 2 | SS | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 125816261 | 12581626 | 3 | C | OXALIPLATIN. | OXALIPLATIN | 1 | 0 | ||||||||||||
| 125816261 | 12581626 | 4 | C | FLUOROURACIL. | FLUOROURACIL | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125816261 | 12581626 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125816261 | 12581626 | Delirium | |
| 125816261 | 12581626 | Drug interaction | |
| 125816261 | 12581626 | Respiratory depression | |
| 125816261 | 12581626 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |